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Neural stem cell-based treatment holds a new therapeutic opportunity for neurodegener-
ative disorders. Here, we investigated the effect of methylene blue on proliferation and
differentiation of rat neural progenitor cells (NPCs) both in vitro and in vivo. We found that
methylene blue inhibited proliferation and promoted quiescence of NPCs in vitro without
affecting committed neuronal differentiation. Consistently, intracerebroventricular infusion
of methylene blue signiﬁcantly inhibited NPC proliferation at the subventricular zone (SVZ).
Methylene blue inhibited mTOR signaling along with down-regulation of cyclins in NPCs
in vitro and in vivo. In summary, our study indicates that methylene blue may delay NPC
senescence through enhancing NPCs quiescence.
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INTRODUCTION
Methylene blue is a heterocyclic aromatic chemical compound
that is used to treat malaria (Dormoi et al., 2013), methe-
moglobinemia (Zenk, 2001), and ifosfamide neurotoxicity (Patel,
2006). Recent studies have identiﬁed its potential neuroprotec-
tive action in ischemic stroke, Parkinson’s disease (Wen et al.,
2011), and Alzheimer’s disease (Congdon et al., 2012). In addi-
tion, MB modulates metabolism as an alternative mitochondrial
electron carrier and enhances mitochondrial oxidative phospho-
rylation (Wen et al., 2011; Poteet et al., 2012, 2013). MB can
induce autophagy to protect neurons from serum deprivation
(Xie et al., 2013). Metabolism is known to play a pivotal role in
dictating whether a cell proliferates, differentiates, or remains
quiescent (Shyh-Chang et al., 2013). Coincidentally, MB has
been demonstrated to delay ﬁbroblast senescence (Atamna et al.,
2008) and inhibit glioblastoma cells proliferation (Poteet et al.,
2013). However, whether MB has effects on NPCs has not been
addressed.
Neural progenitor cells reside in distinct regions of adult mam-
malian brains and have the capacity for self-renewal and giving
rise to three neural lineages through asymmetric cell division
(Gage, 2000). NPCs are involved in the maintenance of normal
brain homeostasis and participate in CNS (central nervous sys-
tem) regeneration and repair (Barkho and Zhao, 2011; Liu and
Rando, 2011). Stem cell exhaustion has been recognized as one
of the hallmarks of aging (López-Otín et al., 2013). Depletion of
Abbreviations: CNS, central nervous system; DCX, doublecortin; GFAP, glial ﬁbril-
lary acidic protein; MAP2, microtubule-associated protein 2; MB, methylene blue;
NPCs, neural progenitor cells; SVZ, subventricular zone.
NPCs, possibly through loss of self-renewal capacity, has been
indicated to be responsible for declining neurogenesis with age
(Renault et al., 2009). Thus, maintenance of self-renewal and pre-
vention of senescence is of great importance for longevity research
and anti-aging therapeutics. In this study, we determined the effect
of MB on the proliferation, self-renewal and differentiation of
NPCs in vitro and in vivo. We demonstrated that MB inhibited
proliferation and promoted quiescence of NPCs, but not affecting
committed neuronal differentiation. In addition, we found that
MB down-regulated mTOR and cyclins expression in NPCs.
MATERIALS AND METHODS
EXPERIMENTAL ANIMALS
All experiments were conducted in compliance with institutional
guidelines and NIH Guidelines for the Use of Animals. All animal
procedures were approved by the University of North Texas Health
Science Center Animal Care and Use Committee. Male Sprague-
Dawley rats weighing 250 – 300 g were purchased from the Jackson
Laboratory. Two mM MB (American Regent, Shirley, NY, USA) in
100 μl of artiﬁcial cerebrospinal ﬂuid was administered into the
left lateral ventricle using Alzet osmotic minipumps (0.5 μl/h)
for 7 days. Bromodeoxyuridine (50 mg/kg BrdU, Sigma-Aldrich,
St. Louis, MO, USA) was intraperitoneally injected twice a day
during the ﬁrst 3 days of MB treatment. All rats were euthanized
and brains were collected for cryosectioning.
NEUROSPHERE CULTURE AND IN VITRO MB TREATMENT
Neurosphere cultures were performed following previous litera-
ture (Imura et al., 2003). Brieﬂy, SVZ of mixed postnatal day 1
rats were digested with 0.25% Trypsin-EDTA (Invitrogen, Grand
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Island,NY,USA) at 37◦C for 30 min. Cells were dissociated by trit-
uration and resuspended at 50,000 cells/ml inNeurobasalmedium
(Invitrogen, Grand Island, NY, USA) supplemented with B27,
10 ng/ml ﬁbroblast growth factor-2 (FGF-2) and 10 ng/ml epi-
dermal growth factor (EGF, both from Peprotech, Rocky Hill, NJ,
USA). Culture medium in the presence or absence of 5 μM MB
was changed every 3 days. To assess the neurosphere formation
in serial passage assay, primary neurospheres were mechanically
dissociated into single cell suspension. 1 × 104 NPCs in 1 ml
of culture medium were incubated for 7 days in 12-well suspen-
sion culture plates. The number of neurospheres was counted
at day 7. Then serial subculture and neurosphere counting was
repeated every 7 days, with 1 × 104 NPCs being seeded at the
beginning of every passage. MB was added into cell suspension
at the ﬁnal concentration of 5 μM at the time of plating cells.
To assess NPC differentiation, neurosphere were triturated into
single cells before plating onto poly-L-lysine-coated coverslips in
Neurobasal medium supplemented with B27 free of FGF2 and
EGF. MB (5 μM) was added at 24 h after plating.
APOPTOSIS ASSAY
Neural progenitor cells were stained with propidium iodide (PI)
and Annexin V-FITC (both from BD Biosciences, Franklin Lakes,
NJ, USA) according to the manufacture’s instruction. Cells were
analyzed on a BD LSRII ﬂow cytometer.
CELL PROLIFERATION AND CELL CYCLE ANALYSIS
For cell proliferation analysis, NPCs were stained with 5 μg/ml
antibody against Ki67 (Abcam, Cambridge, MA, USA). For cell
cycle analysis, NPCs were ﬁxed with 70% ethanol and stained with
PI (40 μg/ml, BD Biosciences, Franklin Lakes, NJ, USA) according
to the manufacture’s instruction. DNA content was analyzed on a
BD LSRII ﬂow cytometer.
IMMUNOCHEMISTRY
Cultured cells were ﬁxed with 4% paraformaldehyde and stained
with anti-MAP2 antibody (Santa Cruz, Dallas, TX, USA) followed
by staining with Alexa Fluor 488-conjugated goat anti-rabbit IgG
(Invitrogen, Grand Island, NY, USA). Fluorescent microscopy was
conducted using an Axio Observer Z1 ﬂuorescent microscope
(Zeiss, Thornwood,NY,USA).On each slide, cells in ﬁve randomly
selected microscopy ﬁelds were counted. For brain section stain-
ing, rats were anesthetized and perfused with neutral-buffered
formalin. The brains were harvested and ﬁxed in neutral-buffered
formalin overnight before sinking in 30% sucrose. Frozen sections
(20μm)wereprepared followedby stainingwithmouse anti-BrdU
mAb and rabbit anti-Nestin antibody (both from Sigma-Aldrich,
St. Louis, MO, USA). Sections were observed on a LSM 410 con-
focal microscope (Zeiss, Thornwood, NY, USA) to record the
z-stack images to conﬁrm colocalization of Nestin and BrdU-
labeled cells in the SVZ. Images were analyzed with the LSM Image
Browser software. BrdU- and Nestin-positive and double-labeled
cells in the SVZ, along the lateral walls of the lateral ventricles
(beginning at 1.18 mm anterior to bregma), were counted in
four sections per animal, spaced 120 μm apart, Results were
expressed as the average number of BrdU- andNestin-positive cells
in SVZ.
WESTERN BLOT
Cells or tissues were lysed in RIPA buffer. The following primary
antibodies were used to detect the proteins of interest: (1) cyclin
antibodies (Cyclin Antibody Sampler Kit, Cell Signaling, Danvers,
MA, USA); (2) mTOR mAb, 4E-BP1 mAb, p70 S6 kinase mAb,
and GAPDH mAb (Cell Signaling, Danvers, MA,USA); (3) mouse
GFAPmAb and rabbit DCXpolyclonal antibody (Santa Cruz,Dal-
las, TX, USA). Protein bands were visualized and optical density
was analyzed using a Biospectrum 500 imaging system (UVP, LLC,
Upland, CA, USA).
REAL-TIME RT-PCR
Total RNAs were extracted using TRIzol and were reversely
transcribed to cDNAs using SuperScript® III First-Strand Syn-
thesis System according to the manufactures’ instructions. Real-
time PCR was performed using Fast SYBR® Green Master
Mix on a 7300 Real-Time PCR System. Reagents and instru-
ments were purchased from Invitrogen, Grand Island, NY,
USA. Data was analyzed with 7300 system software. Primer
sequences for each gene were shown as follows (Forward and
reverse):
Ccnd1: 5′-ACTGACAACTCTATCCGCCC-3′;
5′-TCTGTGCATGTTTGCGGATG-3′.
Ccnd2: 5′-AAAGAGACCATCCCGCTGAC-3′;
5′-TGAAGTCGTGAGGGGTGACT-3′.
Ccnd3: 5′-GTACCGTCTGCCTGTTGCTG-3′;
5′-CAGGAAGTCGTGCGCAATCA-3′.
Ccne1: 5′-CCGACCTCTCAGTCCGATCC-3′;
5′-CCACGCACGCTGAATCATCA-3′.
Ccne2: 5′-CAGGCCTATATATTGAGTTGGCG-3′;
5′-GGCTACTGCGTCTTGACATTC-3′.
Ccna1: 5′-CTGACCGTTCCAACCACCAA-3′;
5′-CTGCTGCTACCAAGGAAGGAA-3′.
Ccna2: 5′-GCCAACTGCAAGGTAGAAAGC-3′;
5′-GCTCCAGCAATAAGCGATGG-3′.
Ccnb1: 5′-TAGATGCAGACGATGGTGGTG-3′;
5′-CAGTGACTTCACGACCCAGTA-3′.
Ccnb2: 5′-TAAGGCGAGCCTCAAAAGCC-3′;
5′-ATGTCGTAGTCGACGAGGGT-3′.
Ccnb3: 5′-GGCACAATGCGAGAAGAACC-3′;
5′-ACTCTGTTAGGGAAGGGGGA-3′.
Map2: 5′-AAGCGGAAAACCACAGCAAC-3′;
5′-GGTCTTGGGAGGGAAGAACG-3′.
Nestin: 5′-GCACACCTCAAGATGTCCCT-3′;
5′-GAACCTCGTCCAGGTGTCTG-3′.
Dcx: 5′-TCACAGCATCTCCACCCAAC-3′;
5′-GTCCATTCATCCGTGACCCT-3′.
Gfap: 5′-GGAGAGGGACAATCTCACACAG-3′;
5′-TTCCTCTCCAGATCCACACGA-3′.
Gapdh: 5′-GATGGTGAAGGTCGGTGTGA-3′;
5′-TGAACTTGCCGTGGGTAGAG-3′.
STATISTICAL ANALYSIS
Data were analyzed and results were presented as mean ± SD.
Student’s t test or one-way ANOVA was used for comparison of
mean between the groups, and p< 0.05was considered statistically
signiﬁcant.
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RESULTS
MB INHIBITS NPCs PROLIFERATION IN VITRO
To determine the potential cytotoxicity of MB, NPCs were treated
with 5 μM MB for 6 days and apoptosis was analyzed. No signiﬁ-
cant change in apoptosis andnecrosis was observed after treatment
(Figure 1A). We then determined the effect of MB on NPC pro-
liferation by Ki67 staining. The proportion of Ki67+ cells were
signiﬁcantly reduced at day 1 and day 3 after MB treatment, com-
pared with control group (Figure 1B). On day 5 after treatment,
NPC proliferation returned to the control level (Figure 1B). Con-
sistently, cell cycle analysis with PI staining indicated that MB
treatment induced signiﬁcant G0/G1 arrest in NPCs at day 1 and
day 3 post-treatment (Figure 1C).
MB DOWN-REGULATES CYCLIN EXPRESSION IN NPCs IN VITRO
Cyclins are a family of proteins that control cell progression
through the cell cycle by activating cyclin-dependent kinases
(Bloom and Cross, 2007; Lange and Calegari, 2010). Having
observed the anti-proliferative effect of MB on NPCs, We then
determined the effect of MB on cyclin expression in NPCs. Since
Figure 1B showed that 1 day treatment had the most robust effect,
we selected this timepoint to investigate. Consistent to its actionon
cell cycle, 24 h treatment with MB down-regulated various NPC
cyclins at mRNA levels and/or protein levels. MB did not affect
cyclin D1, D2, and D3 transcription, but signiﬁcantly reduced
the mRNA levels of cyclin E1, E2, A1, A2, B1, and B3, although
there was an increase in cyclin B2 mRNA (Figure 2A). Western
blot conﬁrmed down-regulated expression of cyclin E1 and B1
after MB treatment (Figures 2B,C). In addition, protein levels
of cyclin D1 and D2 were also down-regulated after MB treat-
ment (Figures 2B,C), suggesting that MB inhibited translation or
enhanced degradation of cyclin D1 and D2.
MB ENHANCES NEUROSPHERE GENERATION IN SERIAL PASSAGE
ASSAY
Neural progenitor cells are able to maintain their relatively
undifferentiated state through self-renewal under both steady
state and pathological conditions. Self-renewal is essential for
stem cells to maintain stem cell pool within organs and tis-
sues (He et al., 2009). To determine whether the MB-induced
NPC quiescence favors neurosphere formation, we ﬁrstly tested
mRNA levels of neural markers to determine NPC differentia-
tion in the suspension culture. We found that NPCs progressively
up-regulated expression of DCX, MAP2, and GFAP even in
suspension culture with growth factors. Nestin and Sox2 expres-
sion were up-regulated from day 1 to day 3 but were reduced
after day 3. MB maintained Nestin and Sox2 expression, while
signiﬁcantly inhibited expression of DCX, MAP2, and GFAP
as compared with vehicle control (Figures 3A–E), suggesting
MB restrained NPCs differentiation in suspension culture. We
then performed serial passage assay to check the self-renewal
capability of NPCs. We found that neurosphere number was
decreased over serial passages in either group, while MB treat-
ment generated more neurospheres from passage 3–6, suggesting
that neurosphere generation was promoted by MB (Figure 3F).
Consistent with less proliferation, MB decreased the total NPC
number in each passage, with the most signiﬁcant decrease
FIGURE 1 | MB inhibits NPC proliferation in vitro. (A) NPC apoptosis
after 6 day MB treatment. Left: representative dot plots. Right: statistical
analysis. (B) Detection of NPC proliferation by Ki67 staining. Left:
representative histograms. Right: statistical analysis. (C) Detection of NPC
cell cycle by PI staining at 1 day and 3 days after MB treatment. Left:
representative histograms. Right: statistical analysis. N = 6 in each group.
Ctrl, control; MB, MB-treated cells. *p < 0.05; **p < 0.01; ***p < 0.001
compared with control group.
displayed in passage 3 and 4 (Figure 3G). Western blot assay con-
ﬁrmed lower expression of DCX and GFAP in MB-treated cells
(Figure 3H), suggesting that differentiation was indeed inhibited
by MB.
MB DOES NOT AFFECT COMMITTED NEURONAL DIFFERENTIATION
FROM NPCs
The other important function of NPCs is to differentiate into
neurons and glia to sustain or repair the CNS structure. To
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FIGURE 2 | MB down-regulates cyclin expression in NPCs.
(A) Detection of mRNA levels of cyclin (D,E,A,B) in NPCs at 24 h after
MB treatment. (B) Western blot assay for cyclin expression in NPCs. This
is a representative of three independent experiments. (C) Statistical
analysis for cyclin protein levels. Expression level was normalized to each
control group at 12 h after culture. N = 6 in each group. Ctrl, control;
MB, MB-treated cells. *p < 0.05; **p < 0.01; ***p < 0.001 compared
with control group.
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FIGURE 3 | MB maintains neurosphere formation capacity of NPCs.
(A–E) Detection of mRNA levels of stem cell, neural and glial markers in
passage 1 (P1) NPCs. N = 3 in each group. (F) Serial passage analysis for
neurosphere formation. N = 6 in each group. (G) Total cell number counting
at the end of each passage. Note that at the beginning of each passage,
only 1 × 104 NPCs were seeded. (H) Western blot assay for Nestin, GFAP
and DCX expression in P1 NPCs treated with MB for 6 days. Left,
representative Western blot image. Right, statistical analysis for expression
level of each protein. *p < 0.05; **p < 0.01; ***p < 0.001 compared with
control group.
test whether MB affected committed neuronal differentiation,
we induced NPCs differentiation by withdrawing growth factors
in adhesion culture for 7 days. Differentiation marker expres-
sions were all robustly up-regulated while Nestin was signiﬁcantly
down-regulated on day 7, suggesting that induction of differen-
tiation was successful (Figure 4A). MB did not signiﬁcantly alter
the expression of MAP2, tubulin β-III and GFAP at 7 days after
growth factors withdraw (Figure 4B). Consistently, immunoﬂuo-
rescence staining showed comparable MAP2 expression in control
and MB-treated cells, indicating that MB did not affect commit-
ted neuronal differentiation (Figures 4C,D). Western blot assay
also demonstrated comparable level of each differentiationmarker
between control and MB-treated groups (Figure 4E). Thus, it
seems that MB does not affect committed neuronal differentiation
from NPCs.
MB INHIBITS TRANSCRIPTION OF mTOR, p70S6K, AND 4EBP1
The close relationship between mTOR signaling and cell cycle
progression has been elucidated elsewhere (Fingar et al., 2004).
Based on the above data showing MB impedes cyclin D trans-
lation, we speculated that MB down-regulates mTOR signaling
to modulate NPC proliferation. So we ﬁrst determined mTOR
activating phosphorylation in MB-treated NPCs. We did observe
decreased mTOR phosphorylation at Ser 2448 after MB treat-
ment. In addition, we found the protein level of total mTOR
was also reduced (Figure 5A). Thus, the decreased phospho-
rylated mTOR is likely due to decreased total mTOR protein.
Then we determined the expression of two target proteins of
mTOR -p70S6K and 4EBP1- in the mTORC1 signal pathway. We
found that MB robustly down-regulated protein levels of both
p70S6K and 4EBP1 (Figures 5B,C). To test whether MB enhances
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FIGURE 4 | MB does not impede committed neuronal differentiation.
(A) Q-RTPCR analysis of the expression of differentiation markers in
differentiated NPCs at 1 and 7 days after growth factors withdraw. N = 3
per group. ***p < 0.001 compared with day-1 differentiated NPCs.
(B) Q-RTPCR for expression of differentiation markers in differentiated
NPCs in the presence or absence of MB. N = 3 per group. (C) Map2
staining for differentiated NPCs in the presence or absence of MB. Upper,
50×; lower, 200×. (D)Total cell number counting and Map2+ cell number
in ﬁve microscopy ﬁelds (50×). (E)Western blot assay for expression of
differentiation markers in differentiated NPCs in the presence or absence of
MB. This is a representative of two independent experiments.
degradation of these proteins, NPCs were co-treated with protea-
some inhibitorMG132. MG132 treatment did not increase protein
levels of mTOR, p70S6K, and 4EBP1 in MB-treated NPCs, sug-
gesting that protein degradation was not involved in MB-induced
down-regulation of these proteins (Figure 5D). Real-time PCR
revealed that MB signiﬁcantly decreased mRNA level of mTOR,
p70S6K and 4EBP1 (Figure 5E). Thus, it seemsMB inhibitsmTOR
transcription and in turn decreases mTOR protein, leading to
reduction of cyclin D translation and inhibition of cell cycle entry.
MB ALLEVIATES NPC PROLIFERATION IN VIVO
To test whether MB also induces NPC quiescence in vivo, MB
was intracerebroventricularly infused into adult rats for 7 days.
FIGURE 5 | MB down-regulates mTOR expression via decreasing
mTOR transcription. (A)Western blot assay of mTOR phosphorylation
in NPCs. This is a representative of two independent experiments.
(B)Western blot assay for the expression of mTOR signaling components
in P1 NPCs. (C) Statistical analysis for protein levels of mTOR, p70S6K, and
4EBP1 after MB treatment. (D)Western blot assay for mTOR, p70S6K, and
4EBP1 in P1 NPCs treated with vehicle, MB, or MB plus proteasome
inhibitor MG132. This is a representative of two independent experiments.
(E) Q-RTPCR for mRNA levels of mTOR, p70S6K and 4EBP1 in P1 NPCs
treated with MB. N = 3 in each group. *p < 0.05; **p < 0.01,
***p < 0.001 compared with control group.
Immunoﬂuorescence staining of Nestin and BrdU demonstrated
less Nestin+/BrdU+ cells at the SVZ inMB-treated rats, suggesting
that MB inhibited NPC proliferation (Figures 6A,B). Consistent
with our in vitro result, MB down-regulated mTOR and cyclin D1
expressions in the SVZ, while down-regulation of p70S6K was not
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FIGURE 6 | MB restrains NPC proliferation in vivo. (A) Detection of NPC
proliferation with Nestin and BrdU staining. Left: representative confocal
microscopy images (100×) of Nestin (green) and BrdU (red) at anterior and
lateral part ventricular wall of SVZ in MB or vehicle treated rats. Arrows
indicate Nestin+/BrdU+ cells. Right: quantiﬁcation of Nestin+ cells and
Nestin+/BrdU+ cells in the SVZ. (B) Representative confocal microscopy
images (400×) of Nestin (green) and BrdU (red) at anterior and lateral part
ventricular wall of SVZ. (C)Western blot assay for mTOR, p70S6K and
cyclin D1 expression at SVZ in MB or vehicle-treated rats. (D) Statistical
analysis for mTOR, p70S6K and cyclin D1 proteins at SVZ in MB or
vehicle-treated rats. *p < 0.05; **p < 0.01 compared with control group.
as signiﬁcant as that in in vitro assay (Figures 6C,D). Hence, we
predicted that MB enhances the quiescence of NPCs by decreasing
mTOR expression in vivo.
DISCUSSION
Neural progenitor cells are captivating given their capacity to
differentiate into multiple brain cell types yet maintain their
undifferentiated state through self-renewal by which a stem cell
divides asymmetrically or symmetrically to generate one or two
daughter stem cells that have the developmental potential of the
mother cell. The ability to self-renewal is essential for stem cells to
expand their numbers during development and to maintain stem
cell pool within adult tissues (He et al., 2009). The slow replen-
ishment of degenerating cells with newly generated neuronal cells
under physiological conditions in vivo has suggested that neu-
ral stem cells basically rest in a state of quiescence, which allows
them to maintain a balance between the ability to undergo self-
renewal and to differentiate without depleting the stem pool. The
importance of stem cell quiescence for the long-term function of
stem cells, including neural stem cells, has been demonstrated
(Cheng et al., 2000; Kippin et al., 2005; Rera et al., 2011). Dysreg-
ulation and loss of quiescence often results in an imbalance in
progenitor cell populations ultimately leading to stem cell deple-
tion (Cheung and Rando, 2013). Thus, how to balance the NPCs
proliferation/differentiation and quiescence to prevent premature
senescence is of great interest in stem cell-related therapeutic
strategies.
In this study we assessed the effect of MB on NPCs, focusing
on two critical aspects of NPCs—quiescence and differentiation.
Quiescence is an important property of adult stem cells for main-
taining stem cell pool and preventing premature senescence. In
vitro growth factor-driven serial passage assay continuously places
neural stem cells under the proliferative stress so as to exhaust their
neurosphere-forming capacity after several passages. MB slowed
NPC proliferation evidenced by the reduction of Ki67 expression.
MB treatment also induced NPC cell cycle arrest. As predicted,
the inhibitory action of MB on NPCs was associated with an
increase of neurosphere generation. Thus, our data indicated that
MB induces NPCs into a relatively quiescent state. Noteworthily,
MB treatment did not alter the expressions of mature neuronal
markers when NPCs were cultured under differentiation condi-
tion. Thus, methylene treatment maintains NPC pool without
affecting committed neuronal differentiation. The in vivo data
proves that MB exerts similar inhibitory action on NPC prolifera-
tion at the SVZ. This is particularly beneﬁcial for patients receiving
MB, since their neuronal development is unlikely to be affected.
Cyclins are a family of proteins that control cell progres-
sion through the cell cycle by activating cyclin-dependent kinases
(Bloom and Cross, 2007; Lange and Calegari, 2010). MB down
regulates various cyclins in NPCs. The pattern of MB-induced
changes of cyclin expression provided further clues for the mech-
anism by which MB modulates NPC proliferation. Our data
demonstrated that MB did not alter mRNA level of cyclin D while
decreasing its protein level, suggesting that MB down-regulated
translation of cyclin D. Expressions of most other cyclins such as
cyclin E, B, and A were also decreased by MB. MB-induced cyclin
D decrease might hamper G0/G1 transition and subsequent cell
cycle progression, resulting in cell cycle arrest, proliferation inhi-
bition and quiescence. The action of MB to reserve quiescent NPC
pool may provide a pharmacological intervention to increase the
longevity of neural stem cells.
The well-known regulatory factor of cyclin D translation is
mTOR, which controls cell growth and metabolism. mTOR
signaling controls cell growth by regulating both translation
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(Vadlakonda et al., 2013) and transcription (Wander et al., 2011)
of cell cycle factors. The close relationship between mTOR signal-
ing and cell cycle progression has been elucidated (Fingar et al.,
2004). Previous studies has indicated the involvement of mTOR
signaling in the maintenance of human embryonic stem cells
(Zhou et al., 2009), NPCs (Han et al., 2013), hematopoietic stem
cells (Chen et al., 2008), and cancer stem cells (Matsubara et al.,
2013). mTOR signaling is also important for both self-renewal and
differentiation of neural stem cells (Magri et al., 2011). mTORC1
inhibition with rapamycin has been shown to improve stem cell
function in the epidermis, in the hematopoietic system, and in
the intestine (Castilho et al., 2009; Chen et al., 2009; Yilmaz et al.,
2012). Recent studies indicated that MB regulates cell signal trans-
duction such asmTOR(Congdonet al.,2012) andAMPKsignaling
(Xie et al., 2013). In our study, MB inhibited the expression of
mTORC1 signaling components, including mTOR, 4EBP1, and
p70 S6 kinase. The association between mTORC1 inhibition and
cyclin D decrease poses the possibility that MB induces NPC qui-
escence through blocking mTORC1 pathway. However, further
studies are in need to elucidate how MB affects expression of
mTORC1 components. Our data is the ﬁrst showing the tran-
scriptional regulation of mTOR by MB. To our surprise, we can
hardly ﬁnd previous publications demonstrating transcriptional
regulation of mTOR. Most research focused on the activation
of mTOR via serine phosphorylation and complex formation. A
recent study indicates that Sox2 suppress mTOR transcription, via
binding at a region about 1.6 kbp upstream of the transcription
start site of the mTOR gene (Wang et al., 2013). Another study
showed that mTOR is overexpressed with loss of the Rb1 fam-
ily pathway (El-Naggar et al., 2009). Whether MB utilizes these
two signal pathways to regulate mTOR transcription needs further
investigation.
In summary, the current study has provided the ﬁrst in vitro
and in vivo evidence that MB treatment promotes NPC qui-
escence through induction of cell cycle arrest. The inhibitory
action of MB on NPC proliferation is accompanied by an inhi-
bition of mTOR signaling. We speculate that MB treatment could
maintain NPCs in a relative quiescence stage without affecting
the differentiation potential. Our ﬁnding warrants future stud-
ies to determine the long term action of MB on NPCs and
functional outcome in healthy and neurodegenerative disease
models.
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